Prevalence of metabolic syndrome and the comparison of fasting plasma glucose and HbA1c as the glycemic criterion for MetS definition in non-diabetic population in Ghana

Table 4 Prevalence of MetS and concordance evaluation between FPG and HbA1c in diagnosing MetS

MetS criteria	Overall	Female	Male
IDF
Model 1	123 (46.6)	92 (58.6)	31 (29.0)
Model 2	143 (54.2)	107 (68.2)	36 (33.6)
Overlap	117 (44.3)	87 (55.4)	30 (28.0)
Kappa	0.759	0.660	0.848
NCEP ATP III
Model 1	98 (37.1)	74 (47.1)	24 (22.4)
Model 2	139 (52.7)	100 (63.7)	39 (36.4)
Overlap	98 (37.1)	74 (47.1)	24 (22.4)
Kappa	0.694	0.674	0.670
WHO
Model 1	33 (12.5)	24 (15.3)	9 (8.4)
Model 2	112 (42.4)	63 (40.1)	49 (45.8)
Overlap	20 (7.6)	14 (8.9)	6 (5.6)
Kappa	0.103	0.129	0.075

Model 1; traditional FPG criteria. Model 2; traditional criteria with the glycemic component replaced by HbA1c. The kappa (ĸ) statistic was used to evaluate the agreement between FPG-(model 1) and HbA1c-based identification of MetS (model 2), Overlap; Diagnosing of same patient with MetS by both FPG and HbA1c

ISSN: 1758-5996